Inositol Treatment in Different Type of PCOS Phenotype

L

Lo.Li.Pharma

Status

Completed

Conditions

Polycystic Ovary Syndrome

Treatments

Dietary Supplement: Myo-inositol

Study type

Interventional

Funder types

Industry

Identifiers

NCT05678114
Ins-PCOSphenotype

Details and patient eligibility

About

Evaluation of the efficacy of inositol treatment in women with PCOS in relation to the phenotype (according to the Rotterdam Criteria)

Enrollment

120 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

women with PCOS of any phenotype

Exclusion criteria

  • hormonal treatment (such as contraceptive pill)
  • use of supplements containing myo-inositol
  • severe co-morbidities

Trial design

120 participants in 2 patient groups

Hyperandrogenic PCOS
Experimental group
Treatment:
Dietary Supplement: Myo-inositol
Non-hyperandrogenic PCOS
Experimental group
Treatment:
Dietary Supplement: Myo-inositol

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems